MARC Record from harvard_bibliographic_metadata

LEADER: 02030cam a22003734a 4500
001 009353856-1
005 20040504114503.0
008 030714s2004 stka b 001 0 eng
010 $a 2003015914
016 7 $a101184778$2DNLM
020 $a044307240X
035 0 $aocm52639324
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dOCLCQ
042 $apcc
050 00 $aRS100$b.P43 2004
060 00 $a2004 A-431
060 10 $aQV 736$bP537 2004
082 00 $a338.4/73621782$222
245 00 $aPharmacoeconomics /$cedited by Tom Walley, Alan Haycox, Angela Boland ; foreword by Alasdair M. Breckenridge.
260 $aEdinburgh ;$aNew York :$bChurchill Livingstone,$c2004.
300 $axii, 203 p. :$bill. ;$c24 cm.
504 $aIncludes bibliographical references and index.
505 0 $aBasics of economics, health economics, and pharmacoeconomics / Alan Haycox, Angela Boland and Tom Walley -- The economics of health care and healthcare systems / Ruth McDonald and Tom Walley -- The policy context for pharmacoeconomics / Ruth McDonald and Tom Walley -- Pharmacoeconomics : an industry perspective / Pippa Anderson, Adam Lloyd, and David Grant -- Disease management and the technique of programme budgeting and marginal analysis / Ruth McDonald, Steve Chapman, and Julia Bottomley -- Cost of illness studies / Tom Walley and Judith Strobl -- Approaches to pharmacoeconomic analysis / Dyfrig Hughes, Antonieta Medina Lara, and Ruben Mujica-Mota -- Pharmacoeconomics and clinical trials / Alan Haycox -- Modelling in health economics / Dyfrig Hughes -- Quality assurance in pharmacoeconomic analyses / Alan Haycox -- The future challenges / Alan Haycox ... [et al.].
650 0 $aDrugs$xCost effectiveness.
650 0 $aPharmaceutical industry$xEconomic aspects.
650 0 $aPharmaceutical policy.
650 0 $aMedical economics.
650 12 $aEconomics, Pharmaceutical.
700 1 $aWalley, Tom.
700 1 $aHaycox, Alan,$d1957-
700 1 $aBoland, Angela.
988 $a20040504
049 $aHLSS
906 $0OCLC